What is Sweet syndrome?

Sweet syndrome is a rare inflammatory condition that causes a sudden onset of:

  • Fever
  • Painful skin rash

It is also known by its medical name, acute febrile neutrophilic dermatosis:

  • Acute = sudden onset
  • Febrile = fever
  • Neutrophilic = involves neutrophils (a type of white blood celll)
  • Dermatosis = skin condition

Although rare (around 3 per million people), it is likely underdiagnosed, meaning more people may have it than reported.

A brief history

Sweet syndrome was first described in 1964 by English dermatologist Dr Robert Sweet, who reported a group of patients with fever and distinctive painful skin lesions.

Who can get Sweet syndrome?

  • Most commonly affects adults over 30 years
  • Slight female predominance (now thought to be closer to equal)
  • Rare in children
  • No clear link to ethnicity

What causes Sweet Syndrome?

The exact cause is not fully understood, but it involves an overactive immune response, particularly involving neutrophils.

In simple terms, the immune system becomes overactivated and doesn’t switch off properly, leading to inflammation in the skin and sometimes other parts of the body.

Common triggers

Sweet syndrome is often triggered by:

  • Infections (especially respiratory or gastrointestinal)
  • Certain medications (e.g. some antibiotics, G-CSF)
  • Autoimmune or inflammatory diseases
  • Pregnancy
  • Cancer (especially blood cancers such as leukaemia)

Some people have genetic markers (e.g. HLA-B54), but this does not mean they will develop the condition.

 

Symptoms of Sweet Syndrome

Symptoms usually develop quickly (over days) and may include:

Skin changes

  • Painful red, purple, or raised lesions
  • May look like bumps, plaques, or nodules
  • Often appear on the face, neck, and arms, but can occur anywhere

General symptoms

  • Fever (often above 38°C)
  • Fatigue and feeling unwell
  • Joint pain
  • Eye inflammation (e.g. redness, irritation)

The rash can appear quite dramatic and may be mistaken for infection or other skin conditions.

 

Diagnosis of Sweet Syndrome

There is no single definitive test. Diagnosis is made using a combination of:

  • Clinical features (typical rash + fever)
  • Blood tests (showing inflammation and increased neutrophils)
  • Skin biopsy, which confirms the diagnosis by showing neutrophil infiltration without blood vessel inflammation

Doctors will also rule out other conditions that can look similar, such as:

  • Vasculitis
  • Erythema nodosum
  • Panniculitis
  • Other inflammatory syndromes

Simplified diagnostic criteria

Doctors typically look for:

Key features:

  • Sudden painful rash
  • Characteristic biopsy findings
  • Plus supporting features (at least two):
    • Fever
    • Recent trigger (infection, cancer, etc.)
    • Abnormal blood tests (inflammation)
    • Rapid response to steroids

Is it autoimmune or autoinflammatory?

Sweet syndrome is considered autoinflammatory, meaning it involves the body’s early (innate) immune system.

However, the boundaries between immune conditions are not always clear, and ongoing research continues to explore this.

 

Treatment for Sweet Syndrome

The main treatment is corticosteroids, which usually work quickly and effectively.

Other treatments (if needed) include:

  • Colchicine
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Targeted therapies (e.g. anakinra, anti-TNF agents)

Most people improve within days to weeks, although complete resolution may take longer.

 

Living with Sweet Syndrome

During active episodes, symptoms can be:

  • Physically uncomfortable
  • Visually noticeable
  • Emotionally distressing

It’s important to:

  • Seek early medical care
  • Follow treatment plans
  • Address both physical and emotional wellbeing

With appropriate care, most people recover well and return to normal life.

What is the outlook?

  • Most patients respond very well to treatment
  • Symptoms can be painful and disruptive, especially during flare-ups
  • The condition can sometimes come back (relapse)
  • A small number of patients develop chronic or recurring disease

Because Sweet syndrome can sometimes be linked to underlying conditions (especially cancers), doctors may recommend further investigations depending on the situation.

When should you seek medical attention?

Seek medical review if you develop:

  • A sudden painful rash
  • Fever with skin changes
  • Symptoms after a new medication or illness

Early treatment can lead to rapid improvement.

Further reading

  • Cohen PR. Sweet syndrome: a comprehensive review (2023)
  • Australasian College of Dermatologists
  • DermNet NZ

IMPORTANT NOTE:

Currently, not all medications commonly used to treat SAIDs are available in Australia and New Zealand, and those available may be difficult to access.

ANZFAID is committed to continuing to advocate for improved options, and timely and affordable access to treatment.

If you love any of the articles on our site we would you love you to share them to help raise awareness.

Medical Disclaimer

The information and support services provided by Australia and New Zealand Forum for AutoInflammatory Diseases Limited (hereafter known as ANZFAID), are intended for general information and peer support purposes only. ANZFAID is a not-for-profit organisation and does not provide medical, diagnostic, or therapeutic advice or treatment.

Nothing on our website, in our publications, at our events, or in any of our communications should be taken as medical advice, nor is it intended to replace consultation with a qualified healthcare professional. Always seek the guidance of your doctor or another qualified health professional with any questions you may have regarding your health or a medical condition.

ANZFAID does not endorse or recommend any specific healthcare provider, treatment, medication, or service. Information shared through our organisation—whether by staff, volunteers, or community members—should not be considered a substitute for professional medical advice.

Use of our services and materials is at your own discretion and risk. While we aim to provide accurate and supportive information, ANZFAID accepts no liability for any loss or damage suffered as a result of reliance on information provided.

All materials contained within this website are subject to copyright and MUST NOT be copied or shared unless in their entirety and with relevant links in place to direct back to the original source on this website.